All lobbying filings

Americans for Responsible Innovation

Americans for Responsible Innovation filed a Q2 report for Americans for Responsible Innovation on July 21, 2025.

Lobbying for Americans for Responsible Innovation · Nonprofit advocacy organization

As filed: AMERICANS FOR RESPONSIBLE INNOVATION for AMERICANS FOR RESPONSIBLE INNOVATION.

All filings by Americans for Responsible Innovation · Everything Americans for Responsible Innovation has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$330,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

SCOTT WEATHERS

Previously held: Energy and Environment Policy Advisor, Rep. Diana DeGette (July 2024-February 2025), Legislative Assistant; Rep. Julia Brownley (June 2023-July 2024); Legislative Fellow, Rep. Matthew Cartwright (February 2023-June 2024)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Consumer Issues/Safety/Products

Issues related to S.146 (TAKE IT DOWN Act) and artificial intelligence.

Computer Industry

Issues related to the responsible governance of artificial intelligence and other emerging technologies.

Science/Technology

Issues related to the responsible governance of artificial intelligence and other emerging technologies.

Budget/Appropriations

Issues related to artificial intelligence and H.R. 1

Medical/Disease Research/Clinical Labs

Issues related to gene synthesis and national security

Trade (domestic/foreign)